Eli Lilly And Co vs Quantumscape Corp — how do they compare? Eli Lilly And Co trades at $1,215.51 (market cap $1.10T), while Quantumscape Corp trades at $6.38 (market cap $3.81B). The key difference: Eli Lilly And Co is far larger — about 288.7× Quantumscape Corp's market cap, and Eli Lilly And Co pays a 0.56% dividend while Quantumscape Corp pays none. Which is the better fit depends on your goals.
| LLY | QS | |
|---|---|---|
Market Cap | $1.10T | $3.81B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.24K | $18.44 |
52-Week Low | $639.43 | $4.89 |
Enterprise Value | $1.14T | $3.02B |
Dividend Yield | 0.56% | — |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,185.71, down 0.59% on the day, with a bullish technical signal from moving averages and strong fundamental momentum. The company reported Q2 2026 revenue growth of 48% to $23 billion, beating estimates, driven by demand for Mounjaro and Zepbound. Valuation ratios like P/E of 39.8 and P/S of 13.34 reflect high growth expectations, while profitability remains robust with a net income margin of 33.53%.
Outlook is positive due to pipeline advancements like retatrutide and raised 2026 guidance, but risks include competitive pressures and regulatory scrutiny. Analysts are bullish with a consensus price target of $1,380, citing sustained double-digit growth and market leadership in weight-loss drugs as key drivers for upside.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →